DNA hypermethylation and the subsequent inactivation of tumor suppressor genes play a key role in AML pathogenesis, with methylation genes (i.e., DNMT3A, TET2, IDH1/2) being among the most frequently mutated in AML [88]. The gene discussed is TET2; the disease is acute myeloid leukemia.